Clinical analysis of hypereosinophilic syndrome first presenting with asthma-like symptoms

References

• Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130(3):607–612.
   PubMed Web of Science ®Google Scholar
• Sunagawa K, Nishio H, Kinukawa N, et al. An autopsy case of disseminated strongyloidiasis combined with cytomegalovirus infection. Jpn J Infect Dis. 2011;64(2):150–152.
   PubMed Web of Science ®Google Scholar
• Mocumbi AO, Goncalves C, Damasceno A, et al. Active schistosomiasis, severe hypereosinophilia and rapid progression of chronic endomyocardial fibrosis. Cardiovasc J Afr. 2016;27(5):e4–e6.
   PubMed Web of Science ®Google Scholar
• Woolnough K, Wardlaw AJ. Eosinophilia in pulmonary disorders. Immunol Allergy Clin North Am. 2015;35(3):477–492.
   PubMed Web of Science ®Google Scholar
• Lima Álvarez J, Peña Griñán N, Simón Pilo I. Eosinophilic pleural effusion as a manifestation of idiopathic hypereosinophilic syndrome. Arch Bronconeumol. 2016;52(10):538.
   PubMed Web of Science ®Google Scholar
• Krenke R, Nasilowski J, Korczynski P, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Resp J. 2009;34(5):1111–1117.
   PubMed Web of Science ®Google Scholar
• Papakosta D, Manika K, Kyriazis G, et al. Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias. Respiration. 2009;78(2):177–184.
   PubMed Web of Science ®Google Scholar
• Spry CJ, Davies J, Tai PC, et al. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med. 1983;52(205):1–22.
   PubMedGoogle Scholar
• Khan WA, Santhanakrishnan K. Hypereosinophilic syndrome secondary to strongyloides infection: a case of recurrent asthma exacerbations. BMJ Case Rep. 2013;2013(1):bcr2013009587–bcr2013009587.
   PubMedGoogle Scholar
• Karnak D, Kayacan O, Beder S, et al. Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma. CMAJ. 2003;168:172–175.
   PubMed Web of Science ®Google Scholar
• Lim KS, Ko J, Lee SS, Shin B, et al. A case of idiopathic hypereosinophilic syndrome presenting with acute respiratory distress syndrome. Allergy Asthma Immunol Res. 2014;6(1):98–101.
   PubMed Web of Science ®Google Scholar
• Xie J, Zhang J, Zhang X, et al. Cough in hypereosinophilic syndrome: case report and literature review. BMC Pulmon Med. 2020;20:1–9.
   PubMed Web of Science ®Google Scholar
• Wu P, Chen Y, Zhang H, et al. Idiopathic hypereosinophilic syndrome presenting with multiple organ damage: a case report. Medicine. 2019;98(10):e14532.
   PubMed Web of Science ®Google Scholar
• Hwang KJ, Heo SH, Chang DI. Multiple microembolic brain infarctions in Clonorchis sinensis infestation. J Neurol Sci. 2012;319(1–2):133–134.
   PubMed Web of Science ®Google Scholar
• Dulohery MM, Patel RR, Schneider F, et al. Lung involvement in hypereosinophilic syndromes. Respir Med. 2011;105(1):114–121.
   PubMed Web of Science ®Google Scholar
• Håkansson KEJ, Rasmussen LJH, Godtfredsen NS, et al. The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study. Respir Res. 2019;20(1):258.
   PubMed Web of Science ®Google Scholar
• Lababidi HM, AlSowayigh OM, BinHowemel SF, et al. Refractory asthma phenotyping based on immunoglobulin E levels and eosinophilic counts: a real life study. Respir Med. 2019;158:55–58.
   PubMed Web of Science ®Google Scholar
• Wijnant SRA, Lahousse L, De Buyzere ML, et al. Prevalence of asthma and COPD AND blood eosinophil count in a Middle-aged belgian population. JCM. 2019;8(8):1122.doi:10.3390/jcm8081122.
   Google Scholar
• Wang JG, Mahmud SA, Thompson JA, et al. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood. 2006;107(2):558–565.
   PubMed Web of Science ®Google Scholar
• Moosbauer C, Morgenstern E, Cuvelier SL, et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood. 2007;109(3):995–1002.
   PubMed Web of Science ®Google Scholar
• Cugno M, Marzano AV, Lorini M, et al. Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. PLOS One. 2014;9(11):e111862.
   PubMed Web of Science ®Google Scholar
• Li D, Xu L, Lin D, et al. Acute pulmonary embolism and deep vein thrombosis secondary to idiopathic hypereosinophilic syndrome. Respir Med Case Rep. 2018;25:213–215.
   PubMed Web of Science ®Google Scholar
• Todd S, Hemmaway C, Nagy Z. Catastrophic thrombosis in idiopathic hypereosinophilic syndrome. Br J Haematol. 2014;165(4):425.
   PubMed Web of Science ®Google Scholar
• Chen TS, Xing LH, Wang SL, et al. Pulmonary embolism, deep vein thrombosis and recurrent bone cysts in a patient with hypereosinophilic syndrome. Blood Coagul Fibrinolysis. 2016;27(7):831–834.
   PubMed Web of Science ®Google Scholar
• Dispenza MC, Bochner BS. Diagnosis and novel approaches to the treatment of hypereosinophilic syndromes. Curr Hematol Malig Rep. 2018;13(3):191–201.
   PubMed Web of Science ®Google Scholar
• Stella S, Massimino M, Manzella L, et al. Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes. IJMS. 2021;22(2):486.
   Google Scholar
• Shomali W, Gotlib J. World health organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019;94(10):1149–1167.
   PubMed Web of Science ®Google Scholar
• Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124(6):1319–1325.
   PubMed Web of Science ®Google Scholar
• Helbig G. Imatinib for the treatment of hypereosinophilic syndromes. Expert Rev Clin Immunol. 2018;14(2):163–170.
   PubMed Web of Science ®Google Scholar
• Hana CK, Caldera H. Hypereosinophilic syndrome, multiorgan involvement and response to imatinib. Cureus. 2020;12(6):e8493.
   PubMed Web of Science ®Google Scholar
• Verstovsek S, Tefferi A, Kantarjian H, et al. Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia. Clin Cancer Res. 2009;15(1):368–373.
   PubMed Web of Science ®Google Scholar
• Jin JJ, Butterfield JH, Weiler CR. Hematologic malignancies identified in patients with hypereosinophilia and hypereosinophilic syndromes. J Allergy Clin Immunol Pract. 2015;3(6):920–925.
   PubMed Web of Science ®Google Scholar